In the face of the menacing Omicron strain, companies such as Sinovac, Cansino, Pfizer, BioNTech, Moderna, Johnson & Johnson, and AstraZeneca have all expressed their active response.
Application of m rna technology in cancer therapyDoriaFang
In the third quarter 2021 financial results, BioNTech not only introduced the latest progress in mRNA infectious disease vaccines, but also introduced the various applications of mRNA technology in the treatment of cancer, showing the broad prospects of mRNA technology.
Covid 19 vaccine from pfizer and biontech was authorized for emergency use in ukDoriaFang
On December 2, 2020, Pfizer and BioNTech announced that the British Medicines & Healthcare Products Regulatory Agency (MHRA) granted a temporary authorization for their COVID-19 mRNA vaccine (BNT162b2) against for COVID-19. It is the first country in the world to be granted emergency use authorization for BNT162b2. Pfizer and BioNTech stated that in the coming days and weeks, it is expected to obtain emergency use authorization in more countries around the world, and both of them are also ready for vaccine supply.
Long acting pe gylated interferon application of pegDoriaFang
Interferons (IFNs) are a group of signaling proteins secreted by host cells in response to the virus infection. The IFNs can be subdivided into three types (types I, II, and III) based on their different receptors.
Download Global cancer immunotoxins market & clinical pipeline insight 2020KuicK Research
“Global Cancer Immunotoxins Market & Clinical Pipeline Insight 2020” Report Highlights:
Introduction to Immunotoxins
Cancer Immunotoxins Therapy Analysis
Advantages of Immunotoxins upon other Anticancerous Drugs
Applications of Immunotoxins to Multiple Cancer Therapies
Global Cancer Immunotoxins Market Future Prospects
Global Cancer Immunotoxins Clinical Pipeline by Company, Indication & Phase
Global Cancer Immunotoxins Clinical Pipeline: 52 Cancer Immunotoxins
Majority Cancer Immunotoxins in Preclinical Phase: 21 Drugs
Global cancer immunotherapy market outlook 2020KuicK Research
"Global Cancer Immunotherapy Market Outlook 2020" Report Highlight:
Introduction & Classification of Cancer Immunotherapy
Global Cancer Immunotherapy Pipeline by Company, Indication & Phase
Marketed Cancer Immunotherapies Clinical Insight & Patent Analysis by Company & Indication
Global Cancer Immunotherapy Pipeline: 1834 Drugs
Marketed Cancer Immunotherapies: 113 Drugs
Cancer Monoclonal Antibodies Pipeline: 622 Cancer mAb
Cancer Vaccines Pipeline: 312 Vaccines
Marketed Cancer mAb: 36 mAb
Marketed Cancer Vaccines: 12 Vaccines
In this SlideShare, we're covering an overview on RNA technologies and recent applications in the field of life sciences. RNA is the pivotal ‘molecule of life’, involved in almost all aspects of cell biology. Recent successes in mRNA-based vaccines indicate just one of the near-infinite possibilities that RNA technology can offer in life sciences.
Application of m rna technology in cancer therapyDoriaFang
In the third quarter 2021 financial results, BioNTech not only introduced the latest progress in mRNA infectious disease vaccines, but also introduced the various applications of mRNA technology in the treatment of cancer, showing the broad prospects of mRNA technology.
Covid 19 vaccine from pfizer and biontech was authorized for emergency use in ukDoriaFang
On December 2, 2020, Pfizer and BioNTech announced that the British Medicines & Healthcare Products Regulatory Agency (MHRA) granted a temporary authorization for their COVID-19 mRNA vaccine (BNT162b2) against for COVID-19. It is the first country in the world to be granted emergency use authorization for BNT162b2. Pfizer and BioNTech stated that in the coming days and weeks, it is expected to obtain emergency use authorization in more countries around the world, and both of them are also ready for vaccine supply.
Long acting pe gylated interferon application of pegDoriaFang
Interferons (IFNs) are a group of signaling proteins secreted by host cells in response to the virus infection. The IFNs can be subdivided into three types (types I, II, and III) based on their different receptors.
Download Global cancer immunotoxins market & clinical pipeline insight 2020KuicK Research
“Global Cancer Immunotoxins Market & Clinical Pipeline Insight 2020” Report Highlights:
Introduction to Immunotoxins
Cancer Immunotoxins Therapy Analysis
Advantages of Immunotoxins upon other Anticancerous Drugs
Applications of Immunotoxins to Multiple Cancer Therapies
Global Cancer Immunotoxins Market Future Prospects
Global Cancer Immunotoxins Clinical Pipeline by Company, Indication & Phase
Global Cancer Immunotoxins Clinical Pipeline: 52 Cancer Immunotoxins
Majority Cancer Immunotoxins in Preclinical Phase: 21 Drugs
Global cancer immunotherapy market outlook 2020KuicK Research
"Global Cancer Immunotherapy Market Outlook 2020" Report Highlight:
Introduction & Classification of Cancer Immunotherapy
Global Cancer Immunotherapy Pipeline by Company, Indication & Phase
Marketed Cancer Immunotherapies Clinical Insight & Patent Analysis by Company & Indication
Global Cancer Immunotherapy Pipeline: 1834 Drugs
Marketed Cancer Immunotherapies: 113 Drugs
Cancer Monoclonal Antibodies Pipeline: 622 Cancer mAb
Cancer Vaccines Pipeline: 312 Vaccines
Marketed Cancer mAb: 36 mAb
Marketed Cancer Vaccines: 12 Vaccines
In this SlideShare, we're covering an overview on RNA technologies and recent applications in the field of life sciences. RNA is the pivotal ‘molecule of life’, involved in almost all aspects of cell biology. Recent successes in mRNA-based vaccines indicate just one of the near-infinite possibilities that RNA technology can offer in life sciences.
vaccine development against COVID-19 by utilizing miRNA technique. Mehedimahidol
Main target to develop a vaccine by using miRNA technique. we hypothesize by using miRNA to attenuate SARS-CoV-2 virus and use this attenuate virus as vaccine. We assumed, this vaccine will work in two different manner , tissue specific and tissue non-specific.
Global gene therapy market & pipeline insightKuicK Research
“Global Gene Therapy Market & Pipeline Insight” Market Highlight:
Gene Therapy Market Overview
Significance of Gene Therapy in Cancer Therapeutics
Current Applications of Gene Therapy to Cancer Treatment
Gene Therapy Market Dynamics: Drivers, Challenges & Future Outlook
FDA & AMA Guidelines for Gene Therapy
Gene Therapy Pipeline by Phase, Indications, Country & Company
Gene Therapy Pipeline: 246 Drugs
Marketed Gene Therapy: 2 (Gendicine & Rexin-G)
Cancer Gene Therapy Pipeline: 69 Drugs
Prospects and Problems of Development of Candidate Vaccine against COVID 19ijtsrd
There is an urgent need to develop a vaccine against coronavirus disease 2019 COVID 19 , which is caused by a new coronavirus, severe acute respiratory syndrome coronavirus type 2 SARS CoV 2 infection. Although vaccine development typically requires 3 to 5 years, there is a possibility that the vaccine developed for either severe acute respiratory syndrome SARS or the middle east respiratory syndrome MERS could be used against COVID 19 as well. Therefore, a vaccine against COVID 19 is expected to be commercialized within 1 to 2 years. If so, it will be the fastest vaccine development in human history.In this review, we have summarized the information released as of April 10, 2020. Takuma Hayashi | Yasuaki Amano | Takashi Ura | Ikuo Konishi "Prospects and Problems of Development of Candidate Vaccine against COVID-19" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-2 , February 2021, URL: https://www.ijtsrd.com/papers/ijtsrd38521.pdf Paper Url: https://www.ijtsrd.com/medicine/other/38521/prospects-and-problems-of-development-of-candidate-vaccine-against-covid19/takuma-hayashi
More than 150 coronavirus vaccines are in development across the world—and hopes are high to bring one to market in record time to ease the global crisis.
The World Health Organization is also coordinating global efforts to develop a vaccine, with an eye toward delivering two billion doses by the end of 2021.
Hello guys , today I am discussing about various stages of vaccine development and types of vaccines already developed by various biotech companies all over the world and their current status in clinical trial till now .
Hope , Very early we can get a ideal corona virus vaccine which would be safe and effective to human and also eradicate this disease from the world .
For more information please follow these link :
https://www.nytimes.com/interactive/2...
https://www.precisionvaccinations.com...
https://www.who.int/publications/m/it...
vaccine development against COVID-19 by utilizing miRNA technique. Mehedimahidol
Main target to develop a vaccine by using miRNA technique. we hypothesize by using miRNA to attenuate SARS-CoV-2 virus and use this attenuate virus as vaccine. We assumed, this vaccine will work in two different manner , tissue specific and tissue non-specific.
Global gene therapy market & pipeline insightKuicK Research
“Global Gene Therapy Market & Pipeline Insight” Market Highlight:
Gene Therapy Market Overview
Significance of Gene Therapy in Cancer Therapeutics
Current Applications of Gene Therapy to Cancer Treatment
Gene Therapy Market Dynamics: Drivers, Challenges & Future Outlook
FDA & AMA Guidelines for Gene Therapy
Gene Therapy Pipeline by Phase, Indications, Country & Company
Gene Therapy Pipeline: 246 Drugs
Marketed Gene Therapy: 2 (Gendicine & Rexin-G)
Cancer Gene Therapy Pipeline: 69 Drugs
Prospects and Problems of Development of Candidate Vaccine against COVID 19ijtsrd
There is an urgent need to develop a vaccine against coronavirus disease 2019 COVID 19 , which is caused by a new coronavirus, severe acute respiratory syndrome coronavirus type 2 SARS CoV 2 infection. Although vaccine development typically requires 3 to 5 years, there is a possibility that the vaccine developed for either severe acute respiratory syndrome SARS or the middle east respiratory syndrome MERS could be used against COVID 19 as well. Therefore, a vaccine against COVID 19 is expected to be commercialized within 1 to 2 years. If so, it will be the fastest vaccine development in human history.In this review, we have summarized the information released as of April 10, 2020. Takuma Hayashi | Yasuaki Amano | Takashi Ura | Ikuo Konishi "Prospects and Problems of Development of Candidate Vaccine against COVID-19" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-2 , February 2021, URL: https://www.ijtsrd.com/papers/ijtsrd38521.pdf Paper Url: https://www.ijtsrd.com/medicine/other/38521/prospects-and-problems-of-development-of-candidate-vaccine-against-covid19/takuma-hayashi
More than 150 coronavirus vaccines are in development across the world—and hopes are high to bring one to market in record time to ease the global crisis.
The World Health Organization is also coordinating global efforts to develop a vaccine, with an eye toward delivering two billion doses by the end of 2021.
Hello guys , today I am discussing about various stages of vaccine development and types of vaccines already developed by various biotech companies all over the world and their current status in clinical trial till now .
Hope , Very early we can get a ideal corona virus vaccine which would be safe and effective to human and also eradicate this disease from the world .
For more information please follow these link :
https://www.nytimes.com/interactive/2...
https://www.precisionvaccinations.com...
https://www.who.int/publications/m/it...
Here's exactly where we're at with vaccines and #reatments for COVID-19!
In this newly published issue of TIF's ''COVID-19 Vaccinations & Therapeutic Drugs'' Guide, you can find out the latest on the current status of COVID-19 vaccinations across the world, the new vaccines and promising treatments, such as molnupiravir, and much more.
Application of oral film technology as a dosage delivery platform for COVID-1...Sridhar Rudravarapu
This presentation updates information on application of quick dissolving oral film technology as a dosage delivery platform for prophylaxis and treatment of COVID-19. The brief review on applications of Oral Films (Oro dispersible & Oro mucosal) indicates the feasibility of using this alternative, convenient and cost effective technology towards mitigation of COVID-19 pandemic globally by the pharmaceutical/health industry.
Computational Docking Study of the Phytochemical Constituent, Silybin (Silybu...Dr Varruchi Sharma
SARS-CoV-2 is continually evolving with the emergence of new variants with increased viral pathogenicity. The emergence of heavily mutated Omicron (B.1.1.529) with spike protein mutations are known to mediate its higher transmissibility and immune escape that has brought newer challenges for global public health to contain SARS-CoV-2 infection. One has to come up with a therapeutic strategy against the virus so as to effectively contain the infection and spread. Natural phytochemicals are being considered a significant source of bioactive compounds possessing an antiviral therapeutic potential. Being a promising anticancer and chemo-preventive agent, Silybin holds a significant potential to be used as a therapeutic. In the present study, molecular docking of Silybin with Omicron spike protein (7QNW) was carried out. Molecular docking results showed greater stability of Silybin in the active site of the Omicron spike protein with suitable binding mode of interactions. The study reveals that Silybin has the potential to block the host ACE2 receptor-viral spike protein binding; thereby inhibiting the viral entry to human cells. Therefore, Silybin may be further developed as a medication with the ability to effectively combat SARS-CoV-2 Omicron.
A pneumonia of unknown cause detected in Wuhan, China was first reported to the WHO
Country Office in China on 31 December 2019.In the last Nine months, almost Ten lakhs of
lives have already been Death, around three billion of people are in quarantine, and global
economies have been decreased. The outbreak of pandemic Covid-19 all over the world has
broken down the political, social, economic, religious and financial structures of the whole
world. The World’s top economies country such as the Australia, USA, India China, UK,
Germany, France, Italy, Japan and many others. The Stock Markets around the world have
been broken down and oil prices have fallen off a cliff. A report was published on BBC where
they describe every single week 3.3 million Americans have been unemployment and a week
later another 6.6 million people started searching for new jobs. The novel coronavirus is a
microscopic organism that has become an epidemic over time around the world. The United
States, Europe, Britain, Italy, Spain and France have already been hit by the virus. These
countries have already become mortal by Corona virus.
Vaccine Development for COVID-19 virus, ranging from all the technologies such as DNA Vaccine, mRNA Vaccine, Whole Inactivated Vaccine, Viral Vector Vaccine. SARS-CoV-2 viral pathology is also shared in this slide.
Similar to Vaccine is expected to be launched early next year against omicron (20)
Cyclic Peptides Current Status & Future Prospects.pdfDoriaFang
Researchers have made unremitting efforts to optimize peptides in order to improve the bioavailability of peptide drugs. Cyclization of peptides is one of the methods to optimize peptides. Cyclic peptides combine several favorable properties such as good binding affinity, target selectivity and low toxicity that make them an attractive modality for the development of therapeutics.
Antibody–Oligonucleotide Conjugates (AOCs) in Clinical Trials.pdfDoriaFang
Summary of Antibody–Oligonucleotide Conjugates(AOCs) in Clinical Trials, including products from Avidity Biosciences, Dyne Therapeutics, Tallac Therapeutics and Denali Therapeutics.
Alzheimer's Disease Drug Development Aducanumab, Lecanemab & Donanemab.pdfDoriaFang
Alzheimer's disease (AD) is a neurodegenerative disorder marked by cognitive and behavioral impairment. Here we introduce the development of AD drugs (Aducanumab, Lecanemab & Donanemab).
Summary of Targeted Protein Degradation in Clinical Trials.pdfDoriaFang
Summary of targeted protein degradation, such as PROTAC and molecular glues in clinical trials. PROTAC and molecular glues are the two main modes of TPD technology based on the UPS.
Cleavable Linkers Used In ADC Development.pdfDoriaFang
The linker used in ADC is divided into two types: cleavable linker and non-cleavable linker. This artile mainly introduced the cleavable linkers used in ADC development.
The Role of Four Lipid Components Of LNPs.pdfDoriaFang
LNP consists of four components: ionizable cationic lipids, phospholipids, cholesterol, and PEG lipids. Each component plays a key role in terms of LNP preparations.
Trophoblast Glycoprotein (TPGB5T4) A New Target For ADC Drugs.pdfDoriaFang
The more popular targets in ADC drugs include HER2, TROP2, EGFR, CLDN18.2, c-Met, CD19, PSMA, Muc1, BCMA and PDL1. Here we will introduce a new ADC target trophoblast glycoprotein (TPBG).
Similar to HER2, Trop-2 is a new hot target for research. Trodelvy has been one of the products receiving much attention in recent years, and Dato-DXd from AstraZeneca/Daiichi Sankyo is also advancing rapidly.
DS-8201 (Enhertu) A Potential ADC Drug Targeting HER2.pdfDoriaFang
Enhertu (fam-Trastuzumab deruxtecan-nxki) is a HER2-targeting ADC drug jointly developed by AstraZeneca and Daiichi Sankyo, also known as DS-8201 or T-DXd.
List of New Anti-cancer Drugs Approved By FDA In The First Half of 2023.pdfDoriaFang
What are the new anti-cancer drugs approved in the first half of the year? The new drugs approved covered a variety of solid tumors and blood tumor types.
Summary of ADC Targets For Solid Tumors & Hematological Tumors.pdfDoriaFang
Currently, popular targets include CD family, BCMA, HER2, TROP2, Tissue factor, Nectin-4, FRα, EGFR, etc. Here, we briefly introduce ADC targets in solid tumors and hematological tumors.
New Oncology Trends ADCs, Bispecific Antibodies & CAR-T Cell.pdfDoriaFang
Scientists are turning their attention to more innovative therapeutic strategies, such as next-generation ADCs, bispecific antibodies and CAR-T cell therapies, etc. as cancer therapy.
Summary of Treatments for Multiple Myeloma.pdfDoriaFang
Currently, there are a variety of drugs available for multiple myeloma, including traditional cytotoxic drugs, immunomodulatory analogs, proteasome inhibitors, antibody-based drugs and CAR T-cell therapy.
Kseniya Leshchenko: Shared development support service model as the way to ma...Lviv Startup Club
Kseniya Leshchenko: Shared development support service model as the way to make small projects with small budgets profitable for the company (UA)
Kyiv PMDay 2024 Summer
Website – www.pmday.org
Youtube – https://www.youtube.com/startuplviv
FB – https://www.facebook.com/pmdayconference
Personal Brand Statement:
As an Army veteran dedicated to lifelong learning, I bring a disciplined, strategic mindset to my pursuits. I am constantly expanding my knowledge to innovate and lead effectively. My journey is driven by a commitment to excellence, and to make a meaningful impact in the world.
Implicitly or explicitly all competing businesses employ a strategy to select a mix
of marketing resources. Formulating such competitive strategies fundamentally
involves recognizing relationships between elements of the marketing mix (e.g.,
price and product quality), as well as assessing competitive and market conditions
(i.e., industry structure in the language of economics).
Putting the SPARK into Virtual Training.pptxCynthia Clay
This 60-minute webinar, sponsored by Adobe, was delivered for the Training Mag Network. It explored the five elements of SPARK: Storytelling, Purpose, Action, Relationships, and Kudos. Knowing how to tell a well-structured story is key to building long-term memory. Stating a clear purpose that doesn't take away from the discovery learning process is critical. Ensuring that people move from theory to practical application is imperative. Creating strong social learning is the key to commitment and engagement. Validating and affirming participants' comments is the way to create a positive learning environment.
Recruiting in the Digital Age: A Social Media MasterclassLuanWise
In this masterclass, presented at the Global HR Summit on 5th June 2024, Luan Wise explored the essential features of social media platforms that support talent acquisition, including LinkedIn, Facebook, Instagram, X (formerly Twitter) and TikTok.
The world of search engine optimization (SEO) is buzzing with discussions after Google confirmed that around 2,500 leaked internal documents related to its Search feature are indeed authentic. The revelation has sparked significant concerns within the SEO community. The leaked documents were initially reported by SEO experts Rand Fishkin and Mike King, igniting widespread analysis and discourse. For More Info:- https://news.arihantwebtech.com/search-disrupted-googles-leaked-documents-rock-the-seo-world/
At Techbox Square, in Singapore, we're not just creative web designers and developers, we're the driving force behind your brand identity. Contact us today.
Affordable Stationery Printing Services in Jaipur | Navpack n PrintNavpack & Print
Looking for professional printing services in Jaipur? Navpack n Print offers high-quality and affordable stationery printing for all your business needs. Stand out with custom stationery designs and fast turnaround times. Contact us today for a quote!
Discover the innovative and creative projects that highlight my journey throu...dylandmeas
Discover the innovative and creative projects that highlight my journey through Full Sail University. Below, you’ll find a collection of my work showcasing my skills and expertise in digital marketing, event planning, and media production.
Buy Verified PayPal Account | Buy Google 5 Star Reviewsusawebmarket
Buy Verified PayPal Account
Looking to buy verified PayPal accounts? Discover 7 expert tips for safely purchasing a verified PayPal account in 2024. Ensure security and reliability for your transactions.
PayPal Services Features-
🟢 Email Access
🟢 Bank Added
🟢 Card Verified
🟢 Full SSN Provided
🟢 Phone Number Access
🟢 Driving License Copy
🟢 Fasted Delivery
Client Satisfaction is Our First priority. Our services is very appropriate to buy. We assume that the first-rate way to purchase our offerings is to order on the website. If you have any worry in our cooperation usually You can order us on Skype or Telegram.
24/7 Hours Reply/Please Contact
usawebmarketEmail: support@usawebmarket.com
Skype: usawebmarket
Telegram: @usawebmarket
WhatsApp: +1(218) 203-5951
USA WEB MARKET is the Best Verified PayPal, Payoneer, Cash App, Skrill, Neteller, Stripe Account and SEO, SMM Service provider.100%Satisfection granted.100% replacement Granted.
3.0 Project 2_ Developing My Brand Identity Kit.pptxtanyjahb
A personal brand exploration presentation summarizes an individual's unique qualities and goals, covering strengths, values, passions, and target audience. It helps individuals understand what makes them stand out, their desired image, and how they aim to achieve it.
What is the TDS Return Filing Due Date for FY 2024-25.pdfseoforlegalpillers
It is crucial for the taxpayers to understand about the TDS Return Filing Due Date, so that they can fulfill your TDS obligations efficiently. Taxpayers can avoid penalties by sticking to the deadlines and by accurate filing of TDS. Timely filing of TDS will make sure about the availability of tax credits. You can also seek the professional guidance of experts like Legal Pillers for timely filing of the TDS Return.
Digital Transformation and IT Strategy Toolkit and TemplatesAurelien Domont, MBA
This Digital Transformation and IT Strategy Toolkit was created by ex-McKinsey, Deloitte and BCG Management Consultants, after more than 5,000 hours of work. It is considered the world's best & most comprehensive Digital Transformation and IT Strategy Toolkit. It includes all the Frameworks, Best Practices & Templates required to successfully undertake the Digital Transformation of your organization and define a robust IT Strategy.
Editable Toolkit to help you reuse our content: 700 Powerpoint slides | 35 Excel sheets | 84 minutes of Video training
This PowerPoint presentation is only a small preview of our Toolkits. For more details, visit www.domontconsulting.com
Digital Transformation and IT Strategy Toolkit and Templates
Vaccine is expected to be launched early next year against omicron
1. Huateng Pharma https://us.huatengsci.com
Vaccine Is Expected to Be Launched Early Next
Year Against Omicron
There are many COVID-19 variants with different transmission, morbidity,
mortality, and ability to evade detection/immunization/treatment. According to
the risk from low to high, World Health Organization (WHO) classifies them as:
1. VUM (Variants Under Monitoring)
2. VOI (Variants of Interest)
3. VOC (Variants of Concern)
Last Friday (November 26), WHO urgently announced the fifth type of VOC,
named after the Greek letter Omicron, the variant also goes by the scientific
name B.1.1.529.
Delta, the predecessor of Omicron, was discovered in India in December 2020,
upgraded to VOI in April 2021, and further upgraded to VOC in June, which
took half a year.
Omicron was reported to the WHO by South Africa on November 24 this
year, and it was listed as a VOC only two days later.
Currently designated Variants of Concern (VOCs)
2. Huateng Pharma https://us.huatengsci.com
Why is the WHO so nervous? Because Omicron carries a lot of mutations.
As a new mutant strain, Omicron has 32 mutation sites on the spike protein of
the novel coronavirus, which is twice as many as the Delta. And there are 10
mutations in the receptor binding domain, which are 5 times as many as Delta.
Spike protein is a key protein that mediates the entry of viruses into human
cells, and is closely related to the speed of virus transmission and immune
escape. A receptor-binding domain (RBD) is a key part of a virus located
on its ‘spike’ domain that allows it to dock to body receptors to gain entry
into cells and lead to infection. Mutations in the spike protein may change the
characteristics of virus invading cells and reduce the immune protection of
existing COVID-19 vaccines and neutralizing antibody therapies. Preliminary
evidence indicates that Omicron may be more infectious than Delta.
Model of structure of novel coronavirus spike receptor-binding domain (pink) complexed
with its receptor ACE2 (blue). (Source:Volodymyr Dvornyk/Shutterstock.com)
In the face of the menacing Omicron strain, companies such as Sinovac,
Cansino, Pfizer, BioNTech, Moderna, Johnson & Johnson, and AstraZeneca
have all expressed their active response.
Sinovac Biotech: Attach great importance and actively respond to
Omicron
On November 28, Sinovac Biotech stated that it will pay close attention to the
new variant of the novel coronavirus variants Omicron, collect and obtain
3. Huateng Pharma https://us.huatengsci.com
relevant information and samples, and understand the impact of the virus on
existing inactivated vaccines as soon as possible. If necessary, Sinovac
Biotech will quickly advance the development and mass production of new
vaccines, and have the ability to guarantee vaccine demand.
CanSinoBio: Has begun to develop vaccines against mutant strains
On November 29, Cansino Biotech stated that it has begun the development of
a vaccine against the new mutant strain of the new coronavirus, Omicron. In
view of the advantages of CanSino's biological adenovirus vector technology
platform and mRNA technology platform, once it is found that the protection of
existing vaccines has decreased, CanSinoBio has confidence to produce a
new vaccine against mutant strains in the shortest time.
Moderna: Development strategy for Omicron
On November 26, Moderna announced its development strategy for Omicron.
The authorized booster vaccine mRNA-1273 (50μg dose) is being used to test
its efficacy against Omicron variants, and the relevant data is expected to be
announced in a few weeks. If it cannot effectively deal with Omicron, Moderna
will develop it from the following three aspects.
Firstly, test the efficacy of higher doses of mRNA-1273 (100 μg) in healthy
volunteers. At present, the safety and immunogenicity research of inoculating
high dose mRNA-1273 in 306 volunteers has been completed.
Secondly, to test the efficacy of two multivalent candidate booster vaccines
(mRNA-1273.211 and mRNA-1273.213) against Omicron.
Thirdly, quickly advance the development of a candidate booster vaccine for
Omicron (mRNA-1273.529).
Pfizer/BioNTech: A vaccine against variant strains can be developed and
produced within 100 days
On November 26, Pfizer/BioNTech stated that it has begun to evaluate the
effectiveness of the mRNA COVID-19 vaccine against the Omicron variant,
and results will be available within two weeks at the latest.
At the same time, if new virus variants appear, Pfizer and BioNTech can
develop and produce related COVID-19 vaccines within 100 days to deal with
"vaccine escape" variants. But it needs to obtain regulatory approval.
4. Huateng Pharma https://us.huatengsci.com
Johnson & Johnson: The effectiveness of Ad26.COV2.S vaccine is
being evaluated
On November 26, Johnson & Johnson stated that it was testing the
effectiveness of the new crown vaccine Ad26.COV2.S (JNJ-78436735)
against the Omicron strain.
JNJ-78436735 is an adenovirus vector vaccine developed and produced using
the AdVac adenovirus vector platform. It is also the first single-dose
vaccination vaccine that has been urgently authorized by the FDA.
In the past few years of the pandemic, countries around the world have
accumulated enough experience in the prevention and control of COVID-19,
and major pharmaceutical companies have gained rich experience in the
development and production of COVID-19 drugs. We can deal with Delta, and
we can definitely defeat Omicron!
Huateng Pharma, a leading supplier of PEG derivatives and pharmaceutical
intermediates. We are capable of supplying small to large quantities of a rich
selection of PEG derivatives and fine chemicals to serve bio-technology and
pharmaceutical companies and research organizations worldwide. We also
supply some PEG products used in COVID-19 mRNA vaccines, such
as DSPA, mPEG-DSPE, mPEG-DTA (ALC-0159) and so on.
Reference:
[1] WHO Names New COVID Strain Omicron, Declares it a 'Variant of Concern'
[2] Coronavirus Resource Center